Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heparin Binding Protein as a Reliable Prognostic Biomarker for Severity of Sepsis in the Intensive Care Unit

NCT05610020 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05610020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05610020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heparin Binding Protein as a Reliable Prognostic Biomarker for Severity of Sepsis in the Intensive Care Unit
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Completed
Start date
October 1, 2021
Completion date
October 1, 2022
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hbp, sepsis